Evaluation of thermoreversible polymers containing fibroblast growth factor 9 (FGF-9) for chondrocyte culture

Journal of Biomedical Materials Research - Part A

Volumn 69, Issue 2, 2004, Pages 367-372

  Au, Angela ^a   Polotsky, Anna ^a   Krzyminski, Karol ^b   Gutowska, Anna ^b   Hungerford, David S ^a   Frondoza, Carmelita G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Chondrocytes; Growth factors; Scaffold; Thermoreversible polymer; Tissue engineering

Indexed keywords

CELL CULTURE; COPOLYMERS; GELS;

CELL PROLIFERATION; CHONDROCYTES;

BIOMATERIALS;

ACRYLIC ACID; AGGRECAN; COLLAGEN TYPE 2; COPOLYMER; FIBROBLAST GROWTH FACTOR 9; POLY(N ISOPROPYLACRYLAMIDE);

ARTICLE; CARTILAGE CELL; CELL COUNT; CELL CULTURE; CELL CULTURE MONITORING; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; GEL; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPERATURE DEPENDENCE; TEMPERATURE SENSITIVITY; TISSUE ENGINEERING;

EID: 1842628893     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.20132     Document Type: Article

References (21)

1. Yang S, Leong K, Du Z, Chua C. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping, techniques. Tissue Eng 2002;8:1-11.
2. Ameer GA, Mahmood TA, Langer R. A biodegradable composite scaffold for cell transplantation. J Orthop Res 2002;20: 16-19.
3. Gutowska A, Jasionowski M, Morris JE, Christler WB, Yuehuei A, Mironov V. Polymer formulations for cartilage repair. In: Proceedings of the 27th Annual Meeting Transactions Society for Biomaterials. Minneapolis, MN: Society for Biomaterials; 2001. p 566.
4. Stile RA, Healy KE. Poly(N-isopropylacrylamide)-based semiinterpenetrating polymer networks for tissue engineering applications. 1. Effects of linear poly(acrylic acid) chains on phase behavior. Biomacromolecules 2002;3:591-600.
5. Stile RA, Burghardt WR, Healy KE. Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro. Macromolecules 1999;32:7370-7379.
6. Stheneur C, Dumontier MF, Guedes C, Fulchignon-Lataud MC, Tahiri K, Karsenty G, Corvol MT. Basic fibroblast growth factor as a selective inducer or matrix Gla protein gene expression in proliferative chondrocytes. Biochem J 2003;369(Pt 1): 63-70.
7. Praul CA, Ford BC, Leach RM. Effect of fibroblast growth factors 1, 2, 4, 5, 6, 7, 8, 9, and 10 on avian chondrocyte proliferation. J Cell Biochem 2002;84:359-366.
8. Aviezer D, Safran M, Yayon A. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2. Biochem Biophys Res Commun 1999;263:621-626.
9. Sato J, Segami N, Suzuki T, Yoshitake Y, Nishikawa K. The expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in chondrocytes in synovial chondromatosis of the temporomandibular joint. Report of two cases. Int J Oral Maxillofac Surg 2002;532-536.
10. Levine A, Kenet G, Bruck R, Avni Y, Avinoach I, Aeed H, Matas Z, David M, Yayon A. Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in rats. Pediatr Res 2002;51:635-640.
11. Seddon AP, Aviezer D, Li LY, Bohlen P, Yayon A. Engineering of fibroblast growth factor: alteration of receptor binding specificity. Biochemistry 1995;34:731-736.
12. Raman R, Venkataraman G, Ernst S, Sasisekharan V, Sasisekharan R. Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc Natl Acad Sci USA 2002;100:2357-2362.
13. Davis RI, Foster H, Arthur K, Trewin S, Hamilton PW, Biggart DJ. Cell proliferation studies in primary synovial chondromatosis. J Pathol 1998;184:18-23.
14. Robinson D, Hasharoni A, Evron Z, Segal M, Nevo Z. Synovial chondromatosis: the possible role of FGF 9 and FGF receptor 3 in its pathology. Int J Exp Pathol 2000;81:183-189.
15. Robinson D, Hasharoni A, Oganesian A, Sandell LJ, Yayon A, Nevo Z. Role of FGF9 and FGF receptor 3 in osteochondroma formation. Orthopedics 2001;24:783-787.
16. Au A, Ha J, Polotsky A, Krzyminski K, Gutowska A, Hungerford DS, Frondoza CG. Thermally reversible polymer gel for chondrocyte culture. J Biomed Mater Res 2003;67A:1310-1319.
17. Frondoza C, Sohrabi A, Hungerford D. Human chondrocytes proliferate and produce matrix components in microcarrier suspension culture. Biomaterials 1996;17:879-888.
18. Lahiji A, Sohrabi A, Hungerford DS, Frondoza CG. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res 2000;51:586-595.
19. Santos-Ocampo S, Colvin JS, Chellaiah A, Omitz DM. Expression and biological activity of mouse fibroblast growth factor-9. J Biol Chem 1996;271:1726-1731.
20. Nakamura S, Todo T, Motoi Y, Haga S, Aizawa T, Ueki A, Ikeda K. Glial expression of fibroblast growth factor-9 in rat central nervous system. Glia 1999;28:53-65.
21. Perez OA, Polotsky AV, Hungerford DS, Frondoza CG. Fibroblast growth factor-9 regulates proliferation and phenotype expression of chondrocytes. Trans 49th Annu Meeting ORS 2003;28:Poster 0562.